PURNIMA TEEGAVARAPU

Concepts (36)

Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.


Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Kidney Neoplasms
4
2017
447
0.880
Why?
Sarcoma, Ewing
1
2017
116
0.480
Why?
Neuroendocrine Tumors
1
2014
59
0.410
Why?
Safety-net Providers
1
2025
70
0.220
Why?
Cystitis
1
2005
51
0.220
Why?
Sulfonamides
2
2016
285
0.210
Why?
Carcinoma, Renal Cell
2
2016
240
0.210
Why?
Eosinophilia
1
2005
106
0.210
Why?
Pyrimidines
2
2016
418
0.200
Why?
Hodgkin Disease
1
2025
301
0.190
Why?
Antineoplastic Agents
2
2016
1824
0.120
Why?
Receptors, Vascular Endothelial Growth Factor
1
2015
104
0.110
Why?
Angiogenesis Inhibitors
1
2015
227
0.100
Why?
Retrospective Studies
5
2025
17419
0.100
Why?
TOR Serine-Threonine Kinases
1
2015
445
0.100
Why?
Nephrectomy
1
2014
178
0.100
Why?
Middle Aged
5
2025
28964
0.090
Why?
Adult
5
2025
31568
0.080
Why?
Combined Modality Therapy
1
2014
1294
0.080
Why?
Treatment Outcome
4
2025
13028
0.080
Why?
Young Adult
3
2025
9957
0.070
Why?
Aged
4
2025
21406
0.060
Why?
Indazoles
2
2016
31
0.060
Why?
Male
5
2025
64922
0.060
Why?
Cystoscopy
1
2005
45
0.060
Why?
Female
5
2025
70712
0.060
Why?
Urinalysis
1
2005
69
0.060
Why?
Prognosis
1
2014
5009
0.050
Why?
Humans
6
2025
132061
0.040
Why?
Algorithms
1
2005
1728
0.030
Why?
Aged, 80 and over
2
2016
7102
0.030
Why?
Disease-Free Survival
1
2016
955
0.030
Why?
Neoplasm Metastasis
1
2016
719
0.030
Why?
Survival Analysis
1
2016
1573
0.020
Why?
Drug Therapy, Combination
1
2015
1180
0.020
Why?
Adolescent
1
2025
20562
0.020
Why?
TEEGAVARAPU's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (36)
Explore
_
Co-Authors (7)
Explore
_
Similar People (60)
Explore
_
Same Department Expand Description
Explore
_